Mucormycosis primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(6 intermediate revisions by 3 users not shown)
Line 6: Line 6:
Mucormycosis may be prevented by avoiding the conditions leading to its development. If we reduce the risk factors, the chance of getting the disease is decreased significantly.
Mucormycosis may be prevented by avoiding the conditions leading to its development. If we reduce the risk factors, the chance of getting the disease is decreased significantly.


==Primary Prevention for Mucormycosis== <ref name="urlMucormycosis Prevention - Epocrates Online">{{cite web |url=https://online.epocrates.com/diseases/92144/Mucormycosis/Prevention |title=Mucormycosis Prevention - Epocrates Online |format= |work= |accessdate=}}</ref>
==Primary Prevention for Mucormycosis==  
Some preventive strategies, may help in decreasing the risk of infection with causative organisms of mucormycosis, such as:
Some preventive strategies may help in decreasing the risk of infection with causative organisms of mucormycosis, such as:<ref name="urlPeople at Risk For Mucormycosis | Mucormycosis | CDC">{{cite web |url=https://www.cdc.gov/fungal/diseases/mucormycosis/risk-prevention.html |title=People at Risk For Mucormycosis &#124; Mucormycosis &#124; CDC |format= |work= |accessdate=}}</ref>
* Balanced use of immunosuppressants like corticosteroids.   
* Balanced use of [[immunosuppressants]] like [[corticosteroids]].   
* Adequate control of blood glucose levels in diabetes.
* Adequate control of blood glucose levels in [[DM|diabetes]].
* Using rooms equipped with high-efficiency particulate air (HEPA) filtration and using masks for patients with severe immunosuppression.
* Using rooms equipped with high-efficiency particulate air ([[HEPA]]) filtration and using masks for patients with severe [[immunosuppression]].
* Treating the underlying chronic disorder leading to debilitation of the patient.
* Treating the underlying chronic disorder leading to debilitation of the patient.
* Using sterilized and decontaminated wound dressings in high risk patients.
* Using [[Sterilization (surgical procedure)|sterilized]] and decontaminated wound dressings in high-risk patients.


==References==
==References==
Line 19: Line 19:
{{WS}}
{{WS}}
{{WH}}
{{WH}}
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Gastroenterology]]
[[Category:Otolaryngology]]
[[Category:Nephrology]]
[[Category:Dermatology]]
[[Category:Pulmonology]]

Latest revision as of 22:46, 29 July 2020

Mucormycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mucormycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Overview

Mucormycosis may be prevented by avoiding the conditions leading to its development. If we reduce the risk factors, the chance of getting the disease is decreased significantly.

Primary Prevention for Mucormycosis

Some preventive strategies may help in decreasing the risk of infection with causative organisms of mucormycosis, such as:[1]

  • Balanced use of immunosuppressants like corticosteroids.
  • Adequate control of blood glucose levels in diabetes.
  • Using rooms equipped with high-efficiency particulate air (HEPA) filtration and using masks for patients with severe immunosuppression.
  • Treating the underlying chronic disorder leading to debilitation of the patient.
  • Using sterilized and decontaminated wound dressings in high-risk patients.

References

  1. "People at Risk For Mucormycosis | Mucormycosis | CDC".

Template:WS Template:WH